Cargando…

Immune correlates of melanoma survival in adoptive cell therapy

The advent of immunotherapies for cancer has resulted in robust clinical responses and confirmed that the immune system can significantly inhibit tumor progression. The recent success of adoptive cell therapy against melanoma suggests that endogenous T-cell responses have the potential to control ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Agnes Fermin, Sieling, Peter A., Lee, Delphine J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601160/ https://www.ncbi.nlm.nih.gov/pubmed/23525606 http://dx.doi.org/10.4161/onci.22889

Ejemplares similares

γδ T cell activation may contribute to antitumor immunity stimulated by intralesional BCG immune therapy for cutaneous melanoma metastases
por: Ramos, Romela, et al.
Publicado: (2015)

Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma
por: Lardone, Ricardo D., et al.
Publicado: (2016)

Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 Levels
por: Leung, Anna M., et al.
Publicado: (2014)

Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin
por: Yang, Junbao, et al.
Publicado: (2017)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function
por: Lardone, Ricardo D., et al.
Publicado: (2017)

Adoptive Cell Therapy for Patients with Melanoma
por: Dudley, Mark E.
Publicado: (2011)

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
por: van Vliet, Amanda A., et al.
Publicado: (2021)

Focus on Adoptive T Cell Transfer Trials in Melanoma
por: Hershkovitz, Liat, et al.
Publicado: (2010)

Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy
por: Jazirehi, Ali R.
Publicado: (2021)

Characterization of a Myeloid Activation Signature That Correlates with Survival in Melanoma Patients
por: Kremenovic, Mirela, et al.
Publicado: (2020)

Adoptive Cell Therapy for T-Cell Malignancies
por: Fang, Karen Kai-Lin, et al.
Publicado: (2022)

Fludarabine Modulates Immune Response and Extends In Vivo Survival of Adoptively Transferred CD8 T Cells in Patients with Metastatic Melanoma
por: Wallen, Herschel, et al.
Publicado: (2009)

Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors
por: Hirai, Ikuko, et al.
Publicado: (2021)

Immune cell labelling and tracking: implications for adoptive cell transfer therapies
por: Galli, Filippo, et al.
Publicado: (2021)

The immune cell landscape of metastatic uveal melanoma correlates with overall survival
por: Tosi, Anna, et al.
Publicado: (2021)

Adoptive T-cell therapy for Leukemia
por: Garber, Haven R, et al.
Publicado: (2014)

Correlation of tumor‐infiltrating immune cells of melanoma with overall survival by immunogenomic analysis
por: Huang, Lili, et al.
Publicado: (2020)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2018)

Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19
por: KALKANLI TAŞ, Sevgi, et al.
Publicado: (2021)

Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy
por: Ortenberg, R., et al.
Publicado: (2015)

Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
por: Khammari, Amir, et al.
Publicado: (2014)

Realizing the Potential for Recipient Immune Cells in Adoptive Immune Therapy
por: Qazi, Sanjive
Publicado: (2016)

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2020)

Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer
por: Sabry, May, et al.
Publicado: (2020)

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
por: Mullinax, John E., et al.
Publicado: (2018)

Is there a future for adoptive cell transfer in melanoma patients?
por: Besser, Michal J
Publicado: (2013)

Immune based therapy for melanoma
por: Ancuceanu, Robert, et al.
Publicado: (2016)

Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan
por: Tsai, Teng‐Huang, et al.
Publicado: (2020)

Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis
por: Yarza, Ramon, et al.
Publicado: (2023)

Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
por: Churov, Alexey V., et al.
Publicado: (2023)

Adoptive T-cell therapy for Hodgkin lymphoma
por: Ho, Carrie, et al.
Publicado: (2021)

Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients
por: Lin, Zhen, et al.
Publicado: (2020)

Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer
por: Neo, Shi Yong, et al.
Publicado: (2023)

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2017)

Challenges and new technologies in adoptive cell therapy
por: Zhang, Pengchao, et al.
Publicado: (2023)

Regulators of Global Genome Repair Do Not Respond to DNA Damaging Therapy but Correlate with Survival in Melanoma
por: Bowden, Nikola A., et al.
Publicado: (2013)

Adoptive T-cell therapy for fungal infections in haematology patients
por: Deo, Shivashni S, et al.
Publicado: (2015)

Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
por: Qin, Shuyang S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_645em212l3mdedjge3bn66lf1q